Drug recall · June 19, 2024
Phenazopyridine HCl Tablets USP recall
Why: Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by: Winder Laboratories, LLC. 716 Patrick Industrial Lane, Winder, GA 30680, NDC 75826-114-10,
- Lots / codes
Lot#: 1142404 Exp. Date 02/27/2027
- Quantity
- 473 cases (5676 Bottles)
- Company
- Winder Laboratories, LLC, Winder, GA
- Distribution
- Nationwide within the United States
- Initiated
- May 28, 2024 · Voluntary: Firm initiated
- Classified
- June 7, 2024
- Reported
- June 19, 2024
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenazopyridine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.